L R Jones1,2, M J W Zwart2, I Q Molenaar3, B Groot Koerkamp4, M E Hogg5, M A Hilal1, M G Besselink2. 1. Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy. 2. Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 3. Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands. 5. Department of Surgery, NorthShore University HealthSystem, Chicago, IL, USA.
Abstract
INTRODUCTION: There has been a rapid development in minimally invasive pancreas surgery in recent years. The most recent innovation is robotic pancreatoduodenectomy. Several studies have suggested benefits as compared to the open or laparoscopic approach. This review provides an overview of studies concerning patient selection, volume criteria, and training programs for robotic pancreatoduodenectomy and identified knowledge gaps regarding barriers for safe implementation of robotic pancreatoduodenectomy. MATERIALS AND METHODS: A Pubmed search was conducted concerning patient selection, volume criteria, and training programs in robotic pancreatoduodenectomy. RESULTS: A total of 20 studies were included. No contraindications were found in patient selection for robotic pancreatoduodenectomy. The consensus and the Miami guidelines advice is a minimum annual volume of 20 robotic pancreatoduodenectomy procedures per center, per year. One training program was identified which describes superior outcomes after the training program and shortening of the learning curve in robotic pancreatoduodenectomy. CONCLUSION: Robotic pancreatoduodenectomy is safe and feasable for all indications when performed by specifically trained surgeons working in centers who can maintain a minimum volume of 20 robotic pancreatoduodenectomy procedures per year. Large proficiency-based training program for robotic pancreatoduodenectomy seem essential to facilitate a safe implementation and future research on robotic pancreatoduodenectomy.
INTRODUCTION: There has been a rapid development in minimally invasive pancreas surgery in recent years. The most recent innovation is robotic pancreatoduodenectomy. Several studies have suggested benefits as compared to the open or laparoscopic approach. This review provides an overview of studies concerning patient selection, volume criteria, and training programs for robotic pancreatoduodenectomy and identified knowledge gaps regarding barriers for safe implementation of robotic pancreatoduodenectomy. MATERIALS AND METHODS: A Pubmed search was conducted concerning patient selection, volume criteria, and training programs in robotic pancreatoduodenectomy. RESULTS: A total of 20 studies were included. No contraindications were found in patient selection for robotic pancreatoduodenectomy. The consensus and the Miami guidelines advice is a minimum annual volume of 20 robotic pancreatoduodenectomy procedures per center, per year. One training program was identified which describes superior outcomes after the training program and shortening of the learning curve in robotic pancreatoduodenectomy. CONCLUSION: Robotic pancreatoduodenectomy is safe and feasable for all indications when performed by specifically trained surgeons working in centers who can maintain a minimum volume of 20 robotic pancreatoduodenectomy procedures per year. Large proficiency-based training program for robotic pancreatoduodenectomy seem essential to facilitate a safe implementation and future research on robotic pancreatoduodenectomy.
Authors: Maurice J W Zwart; Leia R Jones; Ignacio Fuente; Alberto Balduzzi; Kosei Takagi; Stephanie Novak; Luna A Stibbe; Thijs de Rooij; Jony van Hilst; L Bengt van Rijssen; Susan van Dieren; Aude Vanlander; Peter B van den Boezem; Freek Daams; J Sven D Mieog; Bert A Bonsing; Camiel Rosman; Sebastiaan Festen; Misha D Luyer; Daan J Lips; Arthur J Moser; Olivier R Busch; Mohammad Abu Hilal; Melissa E Hogg; Martijn W J Stommel; Marc G Besselink Journal: Surg Endosc Date: 2021-11-19 Impact factor: 3.453